Similarly, the anti-tumor properties of the KD correlated with downregulation of expression levels of pyruvate kinase M2 (PKM2), a key rate-limiting enzyme of glycolysis, in CT26+ colon cancer mouse model [186,187]. Here, DDX53 is linked to malignant colon neoplasm.